The final full week of October featured a fair bit of news away from the ice which is highlighted in our top stories of the week.
Wilson’s Appeal Denied, Appeals Again: NHL Commissioner Gary Bettman upheld the 20-game suspension issued to Capitals winger Tom Wilson for his hit on Blues center Oskar Sundqvist back in the preseason. Notable in the 31-page decision is that the NHLPA argued that a suspension was unwarranted and that Rule 48 was not violated. With that in mind, it comes as little surprise that the appeal has now been made to neutral arbitrator Shyam Das with the hearing slated for Wednesday.
Seattle Realignment Determined: Even though Seattle hasn’t even officially been awarded an expansion franchise yet, the league has already determined its realignment plans for their eventual entry. As expected, Seattle will go into the Pacific Division but rather than have nine teams in there and seven in the Central, the plan is to move Arizona into the Central. As things stand, the plan appears to be to have Seattle join the league in 2020-21 although if their inclusion isn’t made official over the next few months, that could still be pushed back a year.
Schmidt Extension: After locking up Alex Tuch and Shea Theodore to long-term deals in recent weeks, the Golden Knights were at it again, this time inking defenseman Nate Schmidt to a six-year, $35.7MM extension. The deal also contains a ten-team no-trade clause. Schmidt played an instrumental role in the Golden Knights’ run to the Stanley Cup Final last season and has certainly earned the significant raise on his current $2.3MM salary. The 27-year-old has yet to play in the 2018-19 season as he continues to serve a 20-game suspension for testing positive for a performance-enhancing substance over the summer. Vegas now has more than $72MM in committed contracts on the books for next season already.
Namestnikov Garnering Trade Interest: The transition from Tampa Bay to New York has not been kind for center Vladislav Namestnikov. He went from being a legitimate top-six forward with the Lightning to struggling to stay in the lineup with the Rangers. Not surprisingly, he is starting to draw some trade interest around the league as he could be an intriguing buy-low candidate. The 25-year-old is in the first season of a two-year, $8MM deal and will be eligible for unrestricted free agency in the 2020 offseason. Through ten games this season, Namestnikov has just a goal and two assists while logging just over 11 minutes per night.
Boyle’s Cancer In Remission: Saving the best news for last, Devils center Brian Boyle revealed that his cancer is in “full molecular remission”, just under one year since he returned to action. The 2018 Bill Masterton Memorial Trophy winner is off to a quality start to his year with three goals in eight games and really solidifies their depth down the middle. While Boyle will still need to take medication to help ensure that it doesn’t return down the road, he appears to be well on his way towards a full recovery.
Photo courtesy of USA Today Sports Images.